387078006: Spironolactone (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with aldosterone receptor antagonist mechanism of action (substance)\Spironolactone (substance)

\Drug or medicament (substance)\Diuretic (substance)\Potassium-sparing diuretic (substance)\Substance with aldosterone receptor antagonist mechanism of action (substance)\Spironolactone (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Spironolactone (substance)	Is a	Potassium-sparing diuretic (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Spironolactone (substance)	Is a	Substance with aldosterone receptor antagonist mechanism of action (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Spironolactone (substance)	Has disposition	Aldosterone receptor antagonist (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Spironolactone measurement (procedure)	Component	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing spironolactone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Spironolactone adverse reaction	Causative agent (attribute)	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Spironolactone allergy	Causative agent (attribute)	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Spironolactone 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Spironolactone 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Spironolactone 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Spironolactone 5mg/5mL s/f suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Spironolactone 10mg/5mL s/f suspension (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Spironolactone 25mg/5mL s/f suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Spironolactone 50mg/5mL s/f suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Spironolactone 25mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 25 mg and spironolactone 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 50 mg and spironolactone 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Furosemide 20 mg and spironolactone 50 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely hydroflumethiazide 25 milligram and spironolactone 25 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing hydroflumethiazide and spironolactone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Spironolactone and loop diuretic adverse reaction	Causative agent (attribute)	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Spironolactone and thiazide diuretic adverse reaction	Causative agent (attribute)	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Allergy to spironolactone and loop diuretic	Causative agent (attribute)	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Allergy to spironolactone and thiazide diuretic	Causative agent (attribute)	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Spironolactone+loop diuretic	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Spironolactone+thiazide diuretic	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing furosemide and spironolactone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing hydrochlorothiazide and spironolactone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing chlorothiazide and spironolactone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Administration of prophylactic spironolactone (procedure)	Direct substance	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Administration of prophylactic spironolactone (procedure)	Direct substance	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Allergy to spironolactone and loop diuretic	Causative agent (attribute)	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Spironolactone allergy	Causative agent (attribute)	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Allergy to spironolactone and loop diuretic	Causative agent (attribute)	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Allergy to spironolactone and thiazide diuretic	Causative agent (attribute)	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing spironolactone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Spironolactone 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Spironolactone 25 mg oral tablet	Has basis of strength substance (attribute)	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Spironolactone 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Spironolactone 50 mg oral tablet	Has basis of strength substance (attribute)	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Spironolactone 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Spironolactone 100 mg oral tablet	Has basis of strength substance (attribute)	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Furosemide 20 mg and spironolactone 50 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Furosemide 20 mg and spironolactone 50 mg oral capsule	Has basis of strength substance (attribute)	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Furosemide 20 mg and spironolactone 50 mg oral capsule	Has basis of strength substance (attribute)	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet	Has basis of strength substance (attribute)	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydrochlorothiazide 25 mg and spironolactone 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydrochlorothiazide 25 mg and spironolactone 25 mg oral tablet	Has basis of strength substance (attribute)	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydrochlorothiazide 50 mg and spironolactone 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydrochlorothiazide 50 mg and spironolactone 50 mg oral tablet	Has basis of strength substance (attribute)	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely hydroflumethiazide 25 milligram and spironolactone 25 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely hydroflumethiazide 25 milligram and spironolactone 25 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydrochlorothiazide 25 mg and spironolactone 25 mg oral tablet	Has precise active ingredient	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely hydroflumethiazide 25 milligram and spironolactone 25 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Spironolactone 25 mg oral tablet	Has precise active ingredient	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Spironolactone 100 mg oral tablet	Has precise active ingredient	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet	Has precise active ingredient	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydrochlorothiazide 50 mg and spironolactone 50 mg oral tablet	Has precise active ingredient	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Spironolactone 50 mg oral tablet	Has precise active ingredient	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Furosemide 20 mg and spironolactone 50 mg oral capsule	Has precise active ingredient	False	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing hydroflumethiazide and spironolactone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely spironolactone 5 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has basis of strength substance (attribute)	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely spironolactone 5 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has precise active ingredient	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely spironolactone 2 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has basis of strength substance (attribute)	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely spironolactone 2 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has precise active ingredient	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Spironolactone 10 mg/mL oral suspension	Has precise active ingredient	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Spironolactone 10 mg/mL oral suspension	Has basis of strength substance (attribute)	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Spironolactone 1 mg/mL oral suspension	Has basis of strength substance (attribute)	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Spironolactone 1 mg/mL oral suspension	Has precise active ingredient	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydrochlorothiazide- and spironolactone-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing furosemide and spironolactone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only chlorothiazide and spironolactone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydrochlorothiazide and spironolactone only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydroflumethiazide and spironolactone only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only furosemide and spironolactone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Spironolactone only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only furosemide and spironolactone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Spironolactone only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only hydrochlorothiazide and spironolactone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only hydroflumethiazide and spironolactone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Furosemide 20 mg and spironolactone 50 mg oral capsule	Has precise active ingredient	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely spironolactone 50 milligram and torasemide 10 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely spironolactone 50 milligram and torasemide 10 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing spironolactone and torasemide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only spironolactone and torasemide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing spironolactone and torasemide in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only spironolactone and torasemide in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely spironolactone 50 milligram and torasemide 20 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely spironolactone 50 milligram and torasemide 20 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Spironolactone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461256018	Spironolactone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481192019	Spironolactone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1461256018	Spironolactone (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1461256018	Spironolactone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481192019	Spironolactone	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1481192019	Spironolactone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
59051000195115	spironolattone	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
74321000195112	Spironolacton	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
841971000172115	spironolactone	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
841971000172115	spironolactone	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
59051000195115	spironolattone	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
74321000195112	Spironolacton	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module